Export: +91 9820402906   Domestic: +91 7710003340 | HR: +91 9137757219
Diethylcarbamazine citrate DEC tablets

Diethyl Carbamazine Citrate Tablets and DEC Tablets Manufacturer

Active ingredient: Diethylcarbamazine citrate (DEC).

Dosage form: Oral tablets.

Therapeutic category: Antifilarial / antiparasitic medicine.

Strength and pack size: Subject to the approved product specification and market.

B2B enquiries: Manufacturing, export, supply and trading details subject to licensing and confirmation.

Product Information

Diethyl Carbamazine Citrate Tablets and DEC Tablets Manufacturer is listed for pharmaceutical business-to-business enquiries. Exact active ingredients, formulation, strength, pack configuration and manufacturer details should be confirmed against the product label and approved technical documentation before ordering.

Description

1. Product Introduction

Diethylcarbamazine citrate (DEC) is an antiparasitic medicine used in specific filarial infections under medical supervision. This page is intended for licensed pharmaceutical B2B enquiries. Product availability and authorization must be verified for the intended market.

2. Product Specifications

ProductDiethylcarbamazine Citrate Tablets (DEC Tablets)
Active ingredientDiethylcarbamazine citrate
Dosage formOral tablet
Therapeutic classAntifilarial / antiparasitic
StrengthAs specified in the approved formulation and label
PackagingTo be confirmed against the current approved pack specification
Regulatory statusMarket-specific; current registration and availability require confirmation

3. Manufacturing and Quality

Any commercial manufacturing arrangement should be supported by applicable manufacturing licenses, GMP documentation, validated processes, product specifications, stability data and batch-specific certificates of analysis. No particular manufacturing approval or capacity is asserted here.

4. Therapeutic Information

DEC may be used for certain filarial diseases when indicated by a qualified clinician. Its use depends on diagnosis, local treatment guidance and assessment of potential co-infections. It should not be used without professional advice.

5. Safety and Precautions

Adverse reactions may include nausea, headache and dizziness. Treatment of filarial infections may also produce inflammatory reactions related to parasite death. Screening and clinical monitoring may be important, particularly where other filarial infections occur. Follow approved labeling and medical guidance.

6. B2B Export and Supply Enquiries

Licensed buyers may request verification of available strengths, packaging, country-specific registration, minimum order quantities, lead times, quality documentation and commercial terms. Availability is not guaranteed by this listing.

7. Frequently Asked Questions

What does DEC stand for? DEC is the abbreviation for diethylcarbamazine.

Are strengths and pack sizes confirmed? These must be checked against the specific approved product and supplier documentation.

Can export documents be requested? Relevant documentation may be discussed as part of a verified B2B enquiry.

8. Storage and Administration

Store according to the approved product label. Dose and duration must be determined by a qualified healthcare professional; this B2B page does not provide patient-specific dosing instructions.